Regenxbio Inc Capital Reinvestment Ratio

Latest as of March 2025: 0.03x

Regenxbio Inc capital reinvestment ratio. Regenxbio Inc (RGNX) has a Capital Reinvestment Ratio of 0.03x as of March 2025, meaning it reinvests 0% of its operating cash flow ($33.63 Million) in capital expenditures ($1.02 Million). Check cash flow reinvestment rate of Regenxbio Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

$33.63 Million
USD

Capital Expenditures

$1.02 Million
USD

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of Regenxbio Inc (2018–2021)

Capital reinvestment ratio of Regenxbio Inc from 2018 to 2021. This chart tracks Regenxbio Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore RGNX net asset momentum to track the company's year-over-year net asset growth rate.

Regenxbio Inc Capital Reinvestment Ratio by Year (2018–2021)

Regenxbio Inc capital reinvestment ratio by year from 2018 to 2021. For the full cash flow conversion analysis, see RGNX cash generation efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 0.38x $218.88 Million $84.17 Million ▲ +203.1%
2018 0.13x $104.65 Million $13.28 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow